Adaptive Biotechnologies ADPT
NASDAQ ADPT
$28.60 +0.93 (+3.36%)
As of: Sep 17, 2026 · 3:59 PM EDT

Adaptive Biotechnologies (ADPT) Gross Profit Growth (3y) (2021 - 2026)

Analysis

Adaptive Biotechnologies (ADPT) Gross Profit Growth (3y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 60.04%
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 9.05%
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn 9.71%
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn -
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn 47.50%
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 8.43%
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 18.33%
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 23.70%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.33%
Mar 31, 2026 40.11%
Dec 31, 2025 11.46%
Sep 30, 2025 32.05%
Jun 30, 2025 10.33%
Mar 31, 2025 11.73%
Dec 31, 2024 7.66%
Sep 30, 2024 5.60%
Jun 30, 2024 -4.88%
Mar 31, 2024 -5.75%
Dec 31, 2023 2.98%
Sep 30, 2023 -2.83%
Jun 30, 2023 24.49%
Mar 31, 2023 6.80%
Dec 31, 2022 28.35%
Sep 30, 2022 17.19%
Jun 30, 2022 22.88%
Mar 31, 2022 49.06%
Dec 31, 2021 25.53%
Sep 30, 2021 28.81%